NCT04291235
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Not yet recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 16 Years and older (Child, Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must require mechanical ventilation via endotracheal tube for greater than or equal to 48 hours
Exclusions: 
https://ClinicalTrials.gov/show/NCT04291235